Rep. Gilbert Ray Cisneros Jr. (D-CA) Buys GMED Stock
Congressman Cisneros invests in Globus Medical, with a transaction valued between $1,001 and $15,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Ray Cisneros Jr. (D-CA) bought between $1,001 and $15,000 of Globus Medical, Inc. ($GMED) stock on September 3, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 12, 2026.
Since the trade, $GMED is down 5.8% after 1 week, down 2.0% after 1 month and down 1.8% to date (from the $78.12 close on Sep 3, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Ray Cisneros Jr. (D)
- Status:
- Member — House
- Party:
- Democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 12, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Globus Medical, Inc. ($GMED) | Buy | Sep 3, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
GMED
Globus Medical, Inc.
Key Points
- On September 3, 2026, Congressman Gilbert Ray Cisneros Jr. bought shares of Globus Medical, Inc., valued between $1,001 and $15,000.
- Shares of NYSE:GMED traded near $79.30 on Friday, with a market cap of approximately $9.97 billion and a P/E ratio of 19.0.
- Globus Medical, Inc. operates in the healthcare sector, specializing in medical devices, with headquarters in Audubon, PA.
Get $GMED trade alerts by text
We text you when insiders, Congress or big funds trade $GMED. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Globus Medical, Inc. alert may contain errors. Disclosures
Congressman Gilbert Ray Cisneros Jr., a Democrat representing California's 31st district in the House, bought shares of Globus Medical, Inc. (NYSE:GMED) on September 3, 2026. The transaction was valued between $1,001 and $15,000, according to a disclosure filed under the STOCK Act on October 12, 2026.
Gilbert Ray Cisneros Jr. vs. the S&P 500
Hypothetical returns from Gilbert Ray Cisneros Jr.'s disclosed trades, not real profit or advice. How we model this.
Globus Medical, Inc. Stock Up 7.0%
Shares of Globus Medical, Inc. traded near $79.30 on Friday. The company has a market capitalization of about $9.97 billion, with a P/E ratio of 19.0 and a forward P/E of approximately 13.76. Its beta, a measure of volatility compared to the market, is 0.956. Over the past year, the stock has seen a low of $54.15 and a high of $101.40. The company's 50-day moving average is $79.98, while the 200-day moving average stands at $85.24. Globus Medical maintains a current ratio of 4.62 and a quick ratio of 2.78, with a debt-to-equity ratio of 2.35.
Recent Earnings
Globus Medical reported revenue of $3.14 billion, with a growth rate of 5.9%. The company's net margin is 17.0%, and it has a return on equity of 11.81%. The next earnings report is expected on November 5, 2026.
About Globus Medical, Inc.
Globus Medical, Inc. focuses on developing and selling healthcare solutions for musculoskeletal disorders. Based in Audubon, Pennsylvania, the company offers a range of products, including spine and orthopedic trauma solutions, robotic guidance systems, and surgical planning software. Led by CEO Mr. Keith W. Pfeil, Globus Medical employs about 6,000 people and operates internationally in the medical devices industry.
Bottom Line
Rep. Gilbert Ray Cisneros Jr.'s purchase of Globus Medical shares reflects ongoing interest in the healthcare sector, particularly in medical devices. While 13F filings and STOCK Act reports are useful for tracking investment trends among institutional and political figures, they are backward-looking and may not represent current holdings. Investors often watch these filings to gauge confidence in particular sectors or companies.
Related Filing Alerts
Source: Gilbert Ray Cisneros Jr.'s STOCK Act disclosure on $GMED (Sep 3, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts